Albert Bourla: 2025 was a very good year for Pfizer Inc. I'm very pleased with strong execution to deliver and, frankly, overdeliver on our financial commitments. If successful, we will substantially ...

Q3 2026 Earnings Call February 5, 2026 11:00 AM ESTCompany ParticipantsKathy Powers - VP of Investor Relations & ...

In this live Tech Talk, leading industry experts will break down the most common licensing pitfalls, look across organizations of every size, and share a practical approach to getting M365 licensing ...

Q2 2026 Earnings Call February 4, 2026 4:30 PM ESTCompany ParticipantsPaul Silverstein - Vice President of Investor ...